Company Profile

Sino Biopharmaceutical Ltd (OTC: SBHMY)
2:55 PM UTC, 06/25/24
Last: $6.69 Change: -0.51 %Change: -7.08% Volume: 736
Detailed Quote
Open: $ 6.69   Volume: 736
High: $ 6.69   Yield(%) 1.54
Low: $ 6.69   P/E Ratio (ttm): 19.45
Dividend ($): 0.07   Market Cap ($): 6.34B
EPS ($) 1.64   Shares Out: 916.86M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -4.94
% Price Change (last 13 weeks): -8.92
% Price Change (last 26 weeks): -19.39
% Price Change (last 52 weeks): -21.77
% Price Change (year to date): -22.25
Management Effectiveness
Return on Equity (%): 6.23
Return on Assets (%): 2.94
Return on Invested Capital (%): 14.70
Profitability
Gross Profit Margin (%): 80.95
Net Profit Margin (%): 7.22
Operating Profit Margin (%): 22.01
Price & Volume
50-day Moving Average: $1.83
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): 490
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $9.41
52-wk low: $6.68
Bid: $n/a
Ask: $n/a
Company Information
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
Sino Biopharmaceutical Ltd
Office Tower 1 Harbour Road, Convention Plaza Unit 09, 41st Floor, Wanchai
Hong Kong

Phone: 852.2802.9886
Fax: n/a
http://www.sinobiopharm.com
Per Share Data
Earnings (1year) ($): 0.36
Annual Dividend ($): 0.11
Current P/E Ratio (ttm): 19.45
Book Value ($): 4.57
Cash Flow ($): 0.51
Valuation Ratios
Price/Earnings (x): 19.45
Price/Sales (x): 2.23
Price/Book (x): 1.94
Price/Cash Flow (x): 8.82
Financial Strength
Quick Ratio (x): 0.96
Current Ratio (x): 1.05
LT Debt/Equity (x): 4.50
Total Debt/Equity (x): 41.73



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.